Pre-earnings options volume in BioMarin is normal with calls leading puts 7:1. Implied volatility suggests the market is anticipating a move near 2.3%, or $2.01, after results are released. Median move over the past eight quarters is 4.4%.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BMRN:
- BioMarin Announces Strong Second Quarter 2023 Results and Record Breaking Revenues for the First Half of 2023, Including 13% Year Over Year Growth Year-to-date
- BMRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Meta Platforms upgraded, Estee Lauder downgraded: Wall Street’s top analyst call
- BioMarin initiated with a Sector Perform at Scotiabank
- BioMarin price target lowered to $185 from $200 at BofA